Announced Tue, 28 Apr · 20:10 IST
Statement of deviation/variation in use of IPO proceeds (Reg 32)
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹155.40
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.2+5.1+8.8+12.7+14.5+10.9+17.1+19.2+48.3—
Up moveDown movePending
AI summary
The BSE filing page for this announcement was not accessible (error/moved page), so the actual content of the deviation report could not be retrieved. Based on the headline only, Aptus Pharma Ltd has filed a SEBI Reg 32 statement disclosing any deviations or variations in how it has utilised the proceeds from its earlier IPO compared with the objects stated in the prospectus. No specific amounts, objects, or reasons for deviation are available.
Likely market impact
Without the actual document, the impact on shareholders is unclear; such filings can be routine or may flag misuse of IPO funds.